These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 226881)

  • 41. Endoneurial oxygen tension and radial topography in nerve edema.
    Low PA; Nukada H; Schmelzer JD; Tuck RR; Dyck PJ
    Brain Res; 1985 Aug; 341(1):147-54. PubMed ID: 4041783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of the blood-nerve barrier in experimental nerve edema.
    Mizisin AP; Kalichman MW; Myers RR; Powell HC
    Toxicol Pathol; 1990; 18(1 Pt 2):170-85. PubMed ID: 2195637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transperineurial vessel constriction in an edematous neuropathy.
    Kalichman MW; Myers RR
    J Neuropathol Exp Neurol; 1991 Jul; 50(4):408-18. PubMed ID: 2061711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased endoneurial fluid pressure in experimental lead neuropathy.
    Low PA; Dyck PJ
    Nature; 1977 Sep; 269(5627):427-8. PubMed ID: 909590
    [No Abstract]   [Full Text] [Related]  

  • 45. Observations on nature of galactose toxicity in rats.
    CRAIG JM; MADDOCK CE
    AMA Arch Pathol; 1953 Feb; 55(2):118-30. PubMed ID: 13007280
    [No Abstract]   [Full Text] [Related]  

  • 46. Further studies on galactose paralysis in the rat.
    ERSHOFF BH
    Proc Soc Exp Biol Med; 1946 Oct; 63(1):73-5. PubMed ID: 20274268
    [No Abstract]   [Full Text] [Related]  

  • 47. Some unusual causes of pressure neuropathies.
    MARINACCI AA
    Bull Los Angel Neuro Soc; 1960 Dec; 25():223-31. PubMed ID: 13766777
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.
    Fagius J; Jameson S
    J Neurol Neurosurg Psychiatry; 1981 Nov; 44(11):991-1001. PubMed ID: 6801211
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Galactose neuropathy. Permeability studies, mechanism of edema, and mast cell abnormalities.
    Powell HC; Costello ML; Myers RR
    Acta Neuropathol; 1981; 55(2):89-95. PubMed ID: 6274127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Axonal transport in rats after galactose feeding.
    Sidenius P; Jakobsen J
    Diabetologia; 1980 Sep; 19(3):229-33. PubMed ID: 6157595
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pressure-induced inhibition of fast axonal transport of proteins in the rabbit vagus nerve in galactose neuropathy: prevention by an aldose reductase inhibitor.
    McLean WG
    Diabetologia; 1988 Jul; 31(7):443-8. PubMed ID: 2464514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat.
    Dahlin LB; Archer DR; McLean WG
    Diabetologia; 1987 Jun; 30(6):414-8. PubMed ID: 2445613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of nerve compression on fast axonal transport in streptozotocin-induced diabetes mellitus. An experimental study in the sciatic nerve of rats.
    Dahlin LB; Meiri KF; McLean WG; Rydevik B; Sjöstrand J
    Diabetologia; 1986 Mar; 29(3):181-5. PubMed ID: 2422081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Galactose neuropathy: impact of chronic endoneurial edema on nerve blood flow.
    Myers RR; Powell HC
    Ann Neurol; 1984 Nov; 16(5):587-94. PubMed ID: 6095731
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Edema and increased endoneurial sodium in galactose neuropathy. Reversal with an aldose reductase inhibitor.
    Mizisin AP; Powell HC; Myers RR
    J Neurol Sci; 1986 Jun; 74(1):35-43. PubMed ID: 3014066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Schwann cell changes and demyelination in chronic galactose neuropathy.
    Powell HC; Myers RR
    Muscle Nerve; 1983; 6(3):218-27. PubMed ID: 6304510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic and toxic peripheral neuropathies including diabetes.
    Walls TJ
    Curr Opin Neurol Neurosurg; 1992 Jun; 5(3):375-8. PubMed ID: 1320436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frequently asked questions about diabetic peripheral neuropathies.
    Harati Y
    Neurol Clin; 1992 Aug; 10(3):783-807. PubMed ID: 1323753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased endoneurial fluid pressure in galactose neuropathy.
    Myers RR; Costello ML; Powell HC
    Muscle Nerve; 1979; 2(4):299-303. PubMed ID: 226881
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.